MX2010005092A - Formulaciones farmaceuticas. - Google Patents

Formulaciones farmaceuticas.

Info

Publication number
MX2010005092A
MX2010005092A MX2010005092A MX2010005092A MX2010005092A MX 2010005092 A MX2010005092 A MX 2010005092A MX 2010005092 A MX2010005092 A MX 2010005092A MX 2010005092 A MX2010005092 A MX 2010005092A MX 2010005092 A MX2010005092 A MX 2010005092A
Authority
MX
Mexico
Prior art keywords
units
sub
drug substance
pharmaceutical formulations
solid
Prior art date
Application number
MX2010005092A
Other languages
English (en)
Spanish (es)
Inventor
Adrian Brown
Wayne M Matthews
Stephen Mark Mcallister
Danielle Genevieve Rebecca Russell
Lee J Gorringe
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX2010005092A publication Critical patent/MX2010005092A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
MX2010005092A 2007-11-08 2008-11-07 Formulaciones farmaceuticas. MX2010005092A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98638307P 2007-11-08 2007-11-08
PCT/IB2008/003872 WO2009087483A2 (en) 2007-11-08 2008-11-07 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
MX2010005092A true MX2010005092A (es) 2010-05-27

Family

ID=40721919

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005092A MX2010005092A (es) 2007-11-08 2008-11-07 Formulaciones farmaceuticas.

Country Status (12)

Country Link
US (2) US20090148518A1 (enExample)
EP (1) EP2219624A2 (enExample)
JP (1) JP2011503048A (enExample)
KR (1) KR20100096141A (enExample)
CN (1) CN101917978A (enExample)
AU (1) AU2008346205B2 (enExample)
BR (1) BRPI0820381A2 (enExample)
CA (1) CA2705285A1 (enExample)
EA (1) EA201070568A1 (enExample)
MX (1) MX2010005092A (enExample)
TW (1) TW200936186A (enExample)
WO (1) WO2009087483A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
TW200539903A (en) * 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
CN101827573A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 已装填的连接件的制造装置和方法
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
JP2012502883A (ja) * 2008-06-13 2012-02-02 グラクソ グループ リミテッド 医薬製剤
DE102008031426B4 (de) * 2008-07-04 2014-07-31 Schott Ag Verfahren zur Herstellung einer Versiegelungsschicht für Dekorschichten, Glas- oder Glaskeramik-Artikel und dessen Verwendung
DE102008031428A1 (de) * 2008-07-04 2010-01-07 Schott Ag Dekorative Beschichtung von Glas- oder Glaskeramik-Artikeln
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
US9649278B2 (en) 2011-10-12 2017-05-16 Dow Global Technologies Llc Injection-molded dosage form
WO2013090452A1 (en) * 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations
ITTO20120596A1 (it) * 2012-07-06 2014-01-07 Consiglio Nazionale Ricerche Procedimento e sistema per assemblare una forma di dosaggio orale, e forma di dosaggio orale
ES2856187T3 (es) * 2013-05-31 2021-09-27 Victor Bronshtein Composiciones poliméricas que contienen productos biofarmacéuticos estables a temperatura ambiente y métodos para la formulación de las mismas
ES2675002T3 (es) * 2014-04-08 2018-07-05 Dow Global Technologies Llc Dispersión que comprende un éter de celulosa esterificado
US10485758B2 (en) 2014-06-02 2019-11-26 Clexio Biosciences Ltd. Expandable gastroretentive dosage form
TWI535784B (zh) 2014-08-26 2016-06-01 財團法人工業技術研究院 剪切增稠配方、及包含其之複合材料
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
ES2966736T3 (es) 2016-12-02 2024-04-24 Clexio Biosciences Ltd Sistema de residencia gástrica
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
EP3653203A4 (en) 2017-07-11 2020-06-24 Qualicaps Co., Ltd. ENTERAL HARD CAPSULE
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
KR20210022716A (ko) 2018-06-22 2021-03-03 쿠오리카프스 가부시키가이샤 장용성 경질 캡슐

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186910A (en) 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
EP0091908A1 (en) 1981-10-21 1983-10-26 SMITH, Charles E A method and composition for substrate coating
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
EG16027A (en) 1982-03-26 1986-12-30 Warner Lambert Co Hydrophilic polymer composition for injection molding
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4576284A (en) 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US5082655A (en) 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
US5135752A (en) 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5244668A (en) 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5139790A (en) 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
EP0424535A4 (en) 1989-04-21 1991-10-16 Moskovsky Avtomobilestroitelny Institut (Vtuz-Zil) Device for controlled dosing of active substances into an operative medium
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE4431832A1 (de) * 1994-09-07 1996-03-14 Cordes Guenter Dr Arzneimittelzubereitung für ACE-Hemmer
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
JPH09165494A (ja) 1995-11-16 1997-06-24 Yuka Shell Epoxy Kk 硬化性エポキシ樹脂組成物およびその使用
AU5107496A (en) * 1996-03-13 1997-10-01 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Medicament preparation for angiotensin converting enzyme (ace)-inhibitors
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753298A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753297A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19812688A1 (de) 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
IL147826A0 (en) * 1999-07-30 2002-08-14 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
WO2001070201A1 (fr) * 2000-03-23 2001-09-27 Shionogi & Co., Ltd. Preparations granulaires gastro-resistantes constituees de medicaments peu hydrosolubles qui sont caracterises en ce qu'ils contiennent un composant hydroresistant
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
CZ20032225A3 (cs) * 2001-02-27 2003-11-12 Astrazeneca Ab Farmaceutická formulace
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
AU2003262059A1 (en) * 2002-09-11 2004-04-30 Takeda Pharmaceutical Company Limited Sustained release preparation
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
EP1684713A1 (en) * 2003-11-14 2006-08-02 ALZA Corporation Controlled release of topirimate in liquid dosage forms
US20070160677A1 (en) * 2004-01-16 2007-07-12 Pillai Raviraj S Encapsulation of lipid-based formulations in enteric polymers
TW200539903A (en) 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
EP1874274A2 (en) * 2005-04-06 2008-01-09 Mallinckrodt Inc. Matrix-based pulse release pharmaceutical formulation
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations

Also Published As

Publication number Publication date
BRPI0820381A2 (pt) 2015-05-19
US20110117190A1 (en) 2011-05-19
AU2008346205B2 (en) 2012-07-19
AU2008346205A1 (en) 2009-07-16
WO2009087483A3 (en) 2009-10-22
US20090148518A1 (en) 2009-06-11
EA201070568A1 (ru) 2010-12-30
JP2011503048A (ja) 2011-01-27
EP2219624A2 (en) 2010-08-25
TW200936186A (en) 2009-09-01
KR20100096141A (ko) 2010-09-01
CA2705285A1 (en) 2009-07-16
CN101917978A (zh) 2010-12-15
WO2009087483A2 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
WO2009087483A3 (en) Pharmaceutical formulations
MX2010013731A (es) Cubierta de capsula de hidroxipropil celulosa.
MXPA06000791A (es) Formulaciones farmaceuticas.
WO2002060384A3 (en) Pharmaceutical formulation
BRPI0508342A (pt) formulações farmacêuticas
EA201390783A1 (ru) Биоразлагаемые композиции для доставки лекарственных средств
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
WO2007100902A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
EP1948271A4 (en) DISTRACTION OF VISCOUS FORMULATIONS BY NADELLOSIS INJECTION
PL2281576T3 (pl) Polimerowa micela typu aktywnie ukierunkowującego, niosąca zamknięty w niej lek i kompozycja medyczna
WO2008154083A3 (en) Compounds, compositions and methods for the treatment of synucleinopathies
EA201490477A1 (ru) Фармацевтические составы, содержащие пропиленгликоль-гидрат дапаглифлозина
UA110012C2 (uk) Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну
EP1962906A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ANTICREME AND AT LEAST ONE POLYMER
WO2010127205A3 (en) Fixed dose drug combination formulations
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
FR2912746B1 (fr) Nouveaux composes derives d'indole et compositions pharmaceutiques les contenant
EP2643009A4 (en) COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
EP2219725A4 (en) CUFFS FOR ACTIVE INJECTION
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
EP1919288A4 (en) FAMOTIDINE- AND IBUPROGEN-BASED MEDICAMENTS AND THEIR ADMINISTRATION
WO2012097763A3 (en) A carrier for oromucosal, especially sublingual administration of physiologically active substances
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2010109180A8 (en) Composition for the administration of polymeric drugs
EP1981569A4 (en) NADELLOSIS INDIVIDUAL DOSE ADMINISTRATION OF ANTITHROMBOSE MEDICINES

Legal Events

Date Code Title Description
FA Abandonment or withdrawal